US · USD
ELV
Elevance Health Inc
- Day's range
- US$375.74 – US$390.37
- Day's volume
- US$410.8m
- 52-week range
- US$276.69 – US$424.94
Follow ELV on Fuolio
See how ELV weighs in your net worth, what it has paid you and how far it is from your target allocation.
Create a free accountELV in numbers
- Market cap
- US$82.8bn
- P/E
- 16.68
- P/B
- 1.84
- Dividend yield (12m)
- 1.80%
- Net debt/EBITDA
- 2.99
The 12-month dividend yield of ELV is 1.80%, above its 5-year average of 1.39%.
ELV price history
ELV risk and return
Monthly closes adjusted for splits and distributions.
| Metric | 12 months | 36 months | 60 months |
|---|---|---|---|
| Return | +22.72% | -10.84% | -5.63% |
| Volatility (annualised) | 33.29% | 31.74% | 28.40% |
| Largest drawdown | -15.97% | -48.36% | -48.36% |
| Positive months | 6/12 | 21/36 | 31/60 |
How much did investing in ELV return?
US$1,000.00 invested on 01/09/2021 would be worth US$1,122.09 today.
- Value today in ELV
- US$1,122.09
- Return over the period
- +12.21%
- Return per year
- +2.33%
- In the S&P 500
- US$1,776.31
With dividends reinvested, before taxes and costs, at month-end closes. Past returns do not guarantee future ones.
ELV fundamentals
Valuation
- P/E16.68
- P/B1.84
- EV/EBITDA14.87
- EV/EBIT19.00
- EV/Revenue0.52
- P/EBIT15.18
- P/S0.41
- P/OCF11.09
- P/FCF13.16
- Earnings yield5.26%
- PEG ratio—
- Earnings per shareUS$22.88
- Book value per shareUS$206.96
Debt
- Net debtUS$20.8bn
- Net debt/EBITDA2.99
- Net debt/Equity0.46
- Debt/Equity0.69
- Current ratio1.52
- Quick ratio—
- Cash ratio0.23
Efficiency
- Gross margin89.13%
- EBITDA margin3.46%
- Operating margin2.71%
- Net margin2.47%
- Asset turnover1.59
Profitability
- ROE11.06%
- ROA3.93%
- ROIC7.00%
- Payout30.02%
Growth
- Revenue CAGR (5 years)9.25%
- Earnings CAGR (5 years)3.24%
- Revenue growth (year)—
- Earnings growth (year)—
- Revenue growth (quarter)—
- Earnings growth (quarter)—
What is ELV's fair price?
Two classic value formulas, with today's numbers. The current price is US$381.67.
- Graham's fair price
- US$326.44
- 14.47% below the price
√(22.50 × US$22.88 × US$206.96)
Benjamin Graham paid no more than a P/E of 15 and a P/B of 1.5. Their product, 22.5, times earnings (EPS) and book value per share gives the fair price.
- Bazin's ceiling price
- US$96.40
- 74.74% below the price
US$5.78 (5-year average) ÷ 6%
Décio Bazin only bought shares yielding at least 6% a year in distributions. The ceiling price is the average dividend per share of recent years divided by 6%.
Graham ignores growth and debt; Bazin assumes past distributions will repeat. They are reference points for comparison, not a buy recommendation.
ELV indicators by year
Multiples at each year's closing price; margins and returns from that year's accounts.
| Indicator | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|---|---|
| P/E | 13.66 | 14.03 | 18.33 | 20.67 | 18.16 | 17.20 | 15.85 | 18.00 |
| P/B | 1.76 | 2.03 | 2.79 | 3.36 | 3.10 | 2.37 | 2.40 | 2.36 |
| EV/EBITDA | 11.43 | 11.54 | 12.53 | 13.91 | 14.71 | 12.40 | 12.87 | 12.73 |
| Dividend yield | 1.95% | 1.77% | 1.26% | 1.00% | 0.98% | 1.18% | 1.06% | 1.14% |
| Earnings per share | US$25.65 | US$26.30 | US$25.73 | US$24.82 | US$25.52 | US$18.67 | US$19.05 | US$14.59 |
| Book value per share | US$198.83 | US$181.72 | US$168.94 | US$152.63 | US$149.58 | US$135.56 | US$125.74 | US$111.05 |
| ROE | 12.90% | 14.47% | 15.23% | 16.26% | 17.06% | 13.77% | 15.15% | 13.14% |
| ROIC | 9.14% | 9.24% | 11.40% | 12.11% | 10.66% | 9.76% | 10.19% | 9.02% |
| Gross margin | 89.36% | 88.84% | 89.91% | 91.68% | 92.14% | 92.65% | 98.09% | 100.00% |
| EBITDA margin | 4.39% | 5.23% | 5.98% | 6.36% | 6.39% | 6.17% | 6.84% | 7.12% |
| Net margin | 2.84% | 3.38% | 3.49% | 3.76% | 4.44% | 3.75% | 4.61% | 4.07% |
| Net debt/EBITDA | 2.58 | 2.48 | 1.82 | 1.68 | 2.08 | 1.94 | 2.18 | 2.44 |
ELV financial statements
| Line | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|
| Net revenue | US$199.1bn | US$177bn | US$171.3bn | US$156.6bn | US$138.6bn | US$121.9bn |
| Cost of sales | -US$21.2bn | -US$19.8bn | -US$17.3bn | -US$13bn | -US$10.9bn | -US$9bn |
| Gross profit | US$177.9bn | US$157.3bn | US$154bn | US$143.6bn | US$127.7bn | US$112.9bn |
| EBITDA | US$8.7bn | US$9.3bn | US$10.2bn | US$10bn | US$8.9bn | US$7.5bn |
| EBIT | US$7.2bn | US$7.9bn | US$8.5bn | US$8.3bn | US$7.6bn | US$6.4bn |
| Net finance result | — | — | — | — | — | — |
| Profit before tax | US$6.7bn | US$7.9bn | US$7.7bn | US$7.6bn | US$8bn | US$6.2bn |
| Income tax | -US$1bn | -US$1.9bn | -US$1.7bn | -US$1.7bn | -US$1.8bn | -US$1.7bn |
| Net income | US$5.7bn | US$6bn | US$6bn | US$5.9bn | US$6.2bn | US$4.6bn |
Figures the company filed with the CVM. Debt excludes leases; each quarter is that quarter alone.
Does ELV pay dividends?
Dividend yield per year
- 1.20%2017
- 1.14%2018
- 1.06%2019
- 1.18%2020
- 0.98%2021
- 1.00%2022
- 1.26%2023
- 1.77%2024
- 1.95%2025
- 1.35%2026
| Type | Last day to own | Payment | Per share |
|---|---|---|---|
| Dividend | 09/09/2026 | 25/09/2026 | US$1.72 |
| Dividend | 09/06/2026 | 25/06/2026 | US$1.72 |
| Dividend | 09/03/2026 | 25/03/2026 | US$1.72 |
| Dividend | 04/12/2025 | 19/12/2025 | US$1.71 |
| Dividend | 09/09/2025 | 25/09/2025 | US$1.71 |
| Dividend | 09/06/2025 | 25/06/2025 | US$1.71 |
| Dividend | 07/03/2025 | 25/03/2025 | US$1.71 |
| Dividend | 04/12/2024 | 20/12/2024 | US$1.63 |
| Dividend | 09/09/2024 | 25/09/2024 | US$1.63 |
| Dividend | 07/06/2024 | 25/06/2024 | US$1.63 |
| Dividend | 06/03/2024 | 22/03/2024 | US$1.63 |
| Dividend | 04/12/2023 | 21/12/2023 | US$1.48 |
See all 40 distributions
| Type | Last day to own | Payment | Per share |
|---|---|---|---|
| Dividend | 06/09/2023 | 22/09/2023 | US$1.48 |
| Dividend | 07/06/2023 | 23/06/2023 | US$1.48 |
| Dividend | 08/03/2023 | 24/03/2023 | US$1.48 |
| Dividend | 01/12/2022 | 21/12/2022 | US$1.28 |
| Dividend | 07/09/2022 | 23/09/2022 | US$1.28 |
| Dividend | 08/06/2022 | 24/06/2022 | US$1.28 |
| Dividend | 08/03/2022 | 25/03/2022 | US$1.28 |
| Dividend | 01/12/2021 | 21/12/2021 | US$1.13 |
| Dividend | 08/09/2021 | 24/09/2021 | US$1.13 |
| Dividend | 08/06/2021 | 25/06/2021 | US$1.13 |
| Dividend | 08/03/2021 | 25/03/2021 | US$1.13 |
| Dividend | 03/12/2020 | 22/12/2020 | US$0.95 |
| Dividend | 08/09/2020 | 25/09/2020 | US$0.95 |
| Dividend | 08/06/2020 | 25/06/2020 | US$0.95 |
| Dividend | 12/03/2020 | 27/03/2020 | US$0.95 |
| Dividend | 03/12/2019 | 20/12/2019 | US$0.80 |
| Dividend | 06/09/2019 | 25/09/2019 | US$0.80 |
| Dividend | 06/06/2019 | 25/06/2019 | US$0.80 |
| Dividend | 14/03/2019 | 29/03/2019 | US$0.80 |
| Dividend | 03/12/2018 | 21/12/2018 | US$0.75 |
| Dividend | 06/09/2018 | 25/09/2018 | US$0.75 |
| Dividend | 06/06/2018 | 25/06/2018 | US$0.75 |
| Dividend | 07/03/2018 | 23/03/2018 | US$0.75 |
| Dividend | 01/12/2017 | 21/12/2017 | US$0.70 |
| Dividend | 06/09/2017 | 25/09/2017 | US$0.70 |
| Dividend | 06/06/2017 | 23/06/2017 | US$0.65 |
| Dividend | 07/03/2017 | 24/03/2017 | US$0.65 |
| Dividend | 30/11/2016 | 21/12/2016 | US$0.65 |
About Elevance Health
- Sector
- Finance, insurance and real estate
Questions about ELV
How much is ELV today?
ELV is at US$381.67 (-1.84% on the day), last traded on 01/10/2026.
How much did ELV pay in dividends in 2025?
ELV paid US$6.84 per share in 2025, a dividend yield of 1.95%.
What are the P/E and P/B of ELV?
ELV trades at a P/E of 16.68 and a P/B of 1.84.
How much did ELV return in 12 months?
ELV returned 22.72% in 12 months, with annualised volatility of 33.29% and a largest drawdown of -15.97%.